Social
#EULAR2021 recommendations on mgmt of RMD in COVID: continue treatment if symptom free, steroids at lowest dose. @Rheumnow. https://t.co/U5zr7EHvTv
Eric Dein @ejdein1 ( View Tweet )
3 years 11 months ago
What to tell pts with IA about their risk with #COVID19? Depends. Age & major comorbidities (CAD, COPD, HTN, DM, ⬆️ BMI, steroids) are impt. IA pts have ⬆️ ICU admissions & intubation so risk is ⬆️ but pts with IA were older with ⬆️comorbidities vs controls @RheumNow #EULAR2021
Janet Pope @Janetbirdope ( View Tweet )
3 years 11 months ago
What to tell IA pts re response to #CovidVaccine? Global Rheum Alliance showed worse outcomes if on #Rituximab for #SARS_CoV_2 infection OP0006 Good immunity was found with Pfizer vaccine against spike protein but MTX, steroids, MMF blunt response LB003 #EULAR2021 @RheumNow
Janet Pope @Janetbirdope ( View Tweet )
3 years 11 months ago
Wow!
Video vaccine education message directly sent to patient cell phones by SMS is low cost, simple and effective to educate rheum patients about #COVIDvaccine. 76.6% of pts were more likely to take the vaccine.
Abst#OP0009-PARE #EULAR2021 @rheumnow Dr. L Rajagopala https://t.co/OLBOSrmHVR
k dao @KDAO2011 ( View Tweet )
3 years 11 months ago
Starting Thursday we'll be covering EULAR. Tune in for coverage on KOL perspective highlights, clinical trial highlights and much more. https://t.co/L7ryiQ5HdV
Dr. John Cush @RheumNow ( View Tweet )
3 years 11 months ago
A trial of sarilumab in 431 hospitalized COVID-19 patients on supplemental oxygen, Compared to placebo, sarilumab did not improve COVID outcomes https://t.co/postv1eK3F
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 11 months ago
News: Methotrexate Impairs COVID Vax Response
https://t.co/M9d31UAxb7
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 11 months ago
RNL 2021: Best of times, worst of times (Keynote): Dr. Iain McInnes
Dr. Iain McInnes presents his keynote lecture, Best of Times, Worst of Times..., at RheumNow Live 2021.
https://t.co/v3hOYuJZad
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 11 months ago
Preliminary results from 600 pt SAVE-MORE trial in severe COVID, anakinra + standard-of-care was 55% better than SOC in preventing death or respiratory failure; and improving Hosp Discharge by 4 days. Anakinra Rx 100mg/day up to 10 days https://t.co/vbpUMQjC1o
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 11 months ago
News: Factors Associated with COVID-19 Deaths in Rheumatic Patients
https://t.co/FzsINtpZEz https://t.co/QzuLZRKaZy
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 11 months ago
